Veracyte Inc (VCYT)
19.37
-0.86
(-4.25%)
USD |
NASDAQ |
Apr 15, 16:00
19.37
0.00 (0.00%)
After-Hours: 20:00
Veracyte Price to Book Value: 1.393 for April 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 1.393 |
| April 12, 2024 | 1.454 |
| April 11, 2024 | 1.490 |
| April 10, 2024 | 1.489 |
| April 09, 2024 | 1.541 |
| April 08, 2024 | 1.488 |
| April 05, 2024 | 1.447 |
| April 04, 2024 | 1.450 |
| April 03, 2024 | 1.483 |
| April 02, 2024 | 1.475 |
| April 01, 2024 | 1.556 |
| March 28, 2024 | 1.593 |
| March 27, 2024 | 1.562 |
| March 26, 2024 | 1.521 |
| March 25, 2024 | 1.510 |
| March 22, 2024 | 1.516 |
| March 21, 2024 | 1.551 |
| March 20, 2024 | 1.554 |
| March 19, 2024 | 1.558 |
| March 18, 2024 | 1.552 |
| March 15, 2024 | 1.517 |
| March 14, 2024 | 1.528 |
| March 13, 2024 | 1.587 |
| March 12, 2024 | 1.605 |
| March 11, 2024 | 1.629 |
| Date | Value |
|---|---|
| March 08, 2024 | 1.634 |
| March 07, 2024 | 1.636 |
| March 06, 2024 | 1.606 |
| March 05, 2024 | 1.65 |
| March 04, 2024 | 1.692 |
| March 01, 2024 | 1.726 |
| February 29, 2024 | 1.693 |
| February 28, 2024 | 1.709 |
| February 27, 2024 | 1.698 |
| February 26, 2024 | 1.694 |
| February 23, 2024 | 1.595 |
| February 22, 2024 | 1.708 |
| February 21, 2024 | 1.722 |
| February 20, 2024 | 1.756 |
| February 16, 2024 | 1.736 |
| February 15, 2024 | 1.775 |
| February 14, 2024 | 1.791 |
| February 13, 2024 | 1.687 |
| February 12, 2024 | 1.861 |
| February 09, 2024 | 1.794 |
| February 08, 2024 | 1.754 |
| February 07, 2024 | 1.709 |
| February 06, 2024 | 1.786 |
| February 05, 2024 | 1.721 |
| February 02, 2024 | 1.742 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
May 11 2022
16.35
Maximum
Jun 17 2019
3.990
Average
2.667
Median
Price to Book Value Benchmarks
| Fonar Corp | 0.6661 |
| XWELL Inc | 0.2951 |
| ProPhase Labs Inc | 2.24 |
| Applied DNA Sciences Inc | 1.461 |
| OncoCyte Corp | 0.5608 |
Price to Book Value Related Metrics
| PS Ratio | 3.897 |
| PEG Ratio | -0.1774 |
| Price to Free Cash Flow | 41.07 |
| Price | 19.37 |
| Earnings Yield | -5.32% |
| Market Cap | 1.454B |
| PEGY Ratio | -0.1774 |